X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
oncology (58) 58
humans (50) 50
male (38) 38
middle aged (38) 38
female (36) 36
aged (35) 35
article (30) 30
lung neoplasms - drug therapy (26) 26
lung neoplasms - pathology (26) 26
adult (24) 24
aged, 80 and over (24) 24
respiratory system (24) 24
chemotherapy (22) 22
lung neoplasms - genetics (22) 22
neoplasm staging (21) 21
mutation (20) 20
cancer (19) 19
lung cancer (18) 18
carcinoma, non-small-cell lung - drug therapy (17) 17
lung cancer, non-small cell (17) 17
prognosis (16) 16
lung neoplasms - mortality (15) 15
hematology, oncology and palliative medicine (14) 14
immunotherapy (14) 14
adenocarcinoma - genetics (13) 13
carcinoma, non-small-cell lung - pathology (13) 13
survival (13) 13
treatment outcome (13) 13
tumors (12) 12
adenocarcinoma - pathology (11) 11
adenocarcinoma of lung (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
docetaxel (11) 11
erbb receptors - genetics (11) 11
neoadjuvant therapy (11) 11
nivolumab (11) 11
non-small cell lung cancer (11) 11
open-label (11) 11
therapy (11) 11
carcinoma, non-small-cell lung - mortality (10) 10
gefitinib (10) 10
surgery (10) 10
adenocarcinoma (9) 9
adjuvant chemotherapy (9) 9
antineoplastic agents - therapeutic use (9) 9
care and treatment (9) 9
egfr (9) 9
pembrolizumab (9) 9
radiotherapy (9) 9
carcinoma, non-small-cell lung - genetics (8) 8
lung neoplasms - therapy (8) 8
multicenter (8) 8
trial (8) 8
abridged index medicus (7) 7
antibodies, monoclonal - therapeutic use (7) 7
cell lung-cancer (7) 7
lung neoplasms - surgery (7) 7
neoadjuvant chemotherapy (7) 7
preoperative chemotherapy (7) 7
resistance (7) 7
adenocarcinoma - mortality (6) 6
antibodies, monoclonal - adverse effects (6) 6
cardiac & cardiovascular systems (6) 6
health aspects (6) 6
induction chemotherapy (6) 6
ipilimumab (6) 6
lung adenocarcinoma (6) 6
melanoma (6) 6
non-small-cell lung cancer (6) 6
nsclc (6) 6
proto-oncogene proteins - genetics (6) 6
pulmonary and respiratory medicine (6) 6
pulmonary/respiratory (6) 6
ras proteins - genetics (6) 6
survival analysis (6) 6
vinorelbine plus cisplatin (6) 6
young adult (6) 6
adenocarcinoma - drug therapy (5) 5
adenocarcinomas (5) 5
afatinib (5) 5
bevacizumab (5) 5
carboplatin (5) 5
carcinoma, non-small-cell lung - surgery (5) 5
carcinoma, non-small-cell lung - therapy (5) 5
cell biology (5) 5
chemotherapy, adjuvant (5) 5
double-blind (5) 5
erlotinib (5) 5
follow-up studies (5) 5
gene expression (5) 5
international association (5) 5
lung neoplasms - diagnosis (5) 5
lung neoplasms - diagnostic imaging (5) 5
medical colleges (5) 5
metastasis (5) 5
original reports (5) 5
pathologic response (5) 5
phase-ii trial (5) 5
protein kinase inhibitors - therapeutic use (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
Nature Genetics, ISSN 1061-4036, 02/2019, Volume 51, Issue 2, pp. 202 - 206
Immune checkpoint inhibitor (ICI) treatments benefit some patients with metastatic cancers, but predictive biomarkers are needed. Findings in selected cancer... 
CTLA-4 BLOCKADE | THERAPY | LANDSCAPE | PD-1 BLOCKADE | GENETICS & HEREDITY | SENSITIVITY | NEOANTIGENS | Usage | Research | Gene mutations | Immunotherapy | Oncology, Experimental | Cancer | Laboratories | Lung cancer | Melanoma | Histology | Metastasis | Gene expression | Cancer therapies | Patients | Survival | Metastases | Next-generation sequencing | Immune checkpoint | Biomarkers | Mutation | Tumors
Journal Article
Annals of Oncology, ISSN 0923-7534, 2017, Volume 28, Issue 3, pp. 583 - 589
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2018, Volume 29, Issue 6, pp. 1437 - 1444
Abstract Background The composition of gut microbiota affects antitumor immune responses, preclinical and clinical outcome following immune checkpoint... 
Non-small-cell lung cancer | Microbiota | Immune checkpoint inhibitors | Antibiotics | Renal cell carcinoma | microbiota | INTESTINAL MICROBIOTA | immune checkpoint inhibitors | GUT MICROBIOTA | MELANOMA PATIENTS | renal cell carcinoma | THERAPY | ONCOLOGY | IMMUNOTHERAPY | RESISTANCE | NIVOLUMAB | BLOCKADE | antibiotics | CARCINOMA | non-small-cell lung cancer | Original articles
Journal Article
Science Translational Medicine, ISSN 1946-6234, 12/2013, Volume 5, Issue 216, pp. 216ra177 - 216ra177
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 299 - 308
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 10/2018, Volume 13, Issue 10, pp. S284 - S284
Journal Article
Journal Article
Journal Article